close 74% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 74% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Dashboard

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Kodu・Aktsiate loetelu・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Suletud

SektorTervishoid

5.92 -4.82

Tugev "osta" hinnang

Hinna uuendus 24. apr 2025, 19:57 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

5.77

Max

6.32

Põhinäitajad

By Trading Economics

Sissetulek

1.3M

-31M

Müük

-8.2M

31M

Aktsiakasum

-0.24

Kasumimarginaal

-100.779

Töötajad

279

EBITDA

972K

-20M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+798.99% upside

Turustatistika

By TradingEconomics

Turukapital

46M

Eelmine avamishind

10.74

Eelmine sulgemishind

5.92

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

5.9501 / 7.66 Toetus ja vastupanu

Karyopharm Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. apr 2025, 23:54 UTC

Kuumad aktsiad

Stocks to Watch: Alphabet, Intel, AppFolio

DJ

Loe

24. apr 2025, 23:51 UTC

Market Talk

Gold Edges Higher, Supported by U.S. Dollar Weakness -- Market Talk

DJ

Loe

24. apr 2025, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

24. apr 2025, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for Easing U.S.-China Trade Tensions -- Market Talk

DJ

Loe

24. apr 2025, 23:37 UTC

Peamised uudised

Big Tech Braces for Tariff-Induced Advertising Slowdown -- WSJ

DJ

Loe

24. apr 2025, 23:36 UTC

Peamised uudised

Tokyo Consumer Inflation Accelerates in April as Companies Raise Prices

DJ

Loe

24. apr 2025, 23:13 UTC

Peamised uudised
Tulu

Google's Earnings Power Holds Up in Global Turbulence -- Update

DJ

Loe

24. apr 2025, 23:09 UTC

Peamised uudised

Trump Initiatives Knocked Back in a New Round of Court Rulings -- 2nd Update

DJ

Loe

24. apr 2025, 23:02 UTC

Omandamised, ülevõtmised, äriostud

SK Telecom to Sell 10.8M Kakao Shares via After-Hours Block Trading

DJ

Loe

24. apr 2025, 23:02 UTC

Omandamised, ülevõtmised, äriostud

SK Telecom to Dispose of 2.4% Stake in Kakao to Raise KRW413.27B

DJ

Loe

24. apr 2025, 22:51 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update

DJ

Loe

24. apr 2025, 22:48 UTC

Peamised uudised

Walmart Walks the DEI Tightrope in Latest Proxy Statement -- Barrons.com

DJ

Loe

24. apr 2025, 22:47 UTC

Market Talk

Intel Remains in Tough Position, CFRA Research Analyst Says -- Market Talk

DJ

Loe

24. apr 2025, 22:38 UTC

Market Talk
Tulu

Tariffs Hurt Intel's 2Q Outlook as CFO Warns Economic Slowdown is Likely -- Market Talk

DJ

Loe

24. apr 2025, 22:24 UTC

Tulu

Aluminum Corp. of China: Increase in Product Sales Supported 1Q Results >2600.HK

DJ

Loe

24. apr 2025, 22:24 UTC

Tulu

Aluminum Corp. of China 1Q Rev CNY55.78B Vs. CNY48.96B >2600.HK

DJ

Loe

24. apr 2025, 22:24 UTC

Market Talk
Tulu

Intel's Comeback Involves More Engineers, More In-Office Work -- Market Talk

DJ

Loe

24. apr 2025, 22:23 UTC

Tulu

Aluminum Corp. of China 1Q Net CNY3.54B Vs. Net CNY2.23B >2600.HK

DJ

Loe

24. apr 2025, 22:11 UTC

Market Talk
Tulu

Global Equities Roundup: Market Talk

DJ

Loe

24. apr 2025, 22:11 UTC

Market Talk
Tulu

Intel CEO: Layoffs Will Simplify Company Structure -- Market Talk

DJ

Loe

24. apr 2025, 22:09 UTC

Peamised uudised
Tulu

Intel Cuts Outlook, Says Layoffs Are in Store -- Update

DJ

Loe

24. apr 2025, 22:00 UTC

Market Talk
Tulu

T-Mobile's Key Subscriber Metric Disappoints Despite Earnings Beat -- Market Talk

DJ

Loe

24. apr 2025, 21:39 UTC

Peamised uudised

Trump Initiatives Knocked Back in a New Round of Court Rulings -- WSJ

DJ

Loe

24. apr 2025, 21:24 UTC

Peamised uudised
Tulu

Bristol Myers Reports Better-Than-Expected Earnings. The Future Is Cloudy. -- Barrons.com

DJ

Loe

24. apr 2025, 21:24 UTC

Peamised uudised
Tulu

Google's Earnings Power Holds Up in Global Turbulence -- WSJ

DJ

Loe

24. apr 2025, 21:23 UTC

Peamised uudised
Tulu

Intel Cuts Outlook, Says Layoffs Are in Store -- WSJ

DJ

Loe

24. apr 2025, 21:04 UTC

Tulu

T-Mobile Reports Strong Earnings but Its Wireless Results Disappoint. The Stock Is Sliding. -- Barrons.com

DJ

Loe

24. apr 2025, 21:03 UTC

Tulu

Agnico-Eagle Mines Believes Its Rev Structure Will Be Largely Unaffected by the Tariffs >AEM.T

DJ

Loe

24. apr 2025, 21:03 UTC

Tulu

Agnico-Eagle Mines Total Expected Capex for 2025 Still Estimated at $1.75 B to $1.95 B >AEM.T

DJ

Loe

24. apr 2025, 21:02 UTC

Tulu

Agnico-Eagle Mines Positioned to Achieve 2025 AISC Per Ounce Guidance of $1,250 to $1,300. >AEM.T

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Karyopharm Therapeutics Inc Prognoos

Hinnasiht

By TipRanks

798.99% tõus

12 kuu keskmine prognoos

Keskmine 53.67 USD  798.99%

Kõrge 105 USD

Madal 15 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Karyopharm Therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

6 ratings

5

Osta

1

Hoia

0

Müü

Põhineb 6 analüütiku instrumendi Karyopharm Therapeutics Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

5.9501 / 7.66Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Recent bullish events outweigh bearish events.

Keskpikk perspektiiv

Strong Bearish Evidence

All events are bearish.

Pikk perspektiiv

No Evidence

There are no events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

MDT

Medtronic PLC

83.58

↓-0.61%

VEEV

Veeva Systems Inc

225.8

↑ +0.45%

A

Agilent Technologies Inc

105.71

↑ +0.08%

WBA

Walgreens Boots Alliance Inc

10.98

↓-0.18%

CHE

Chemed Corp

548.09

↓-0.97%